A sensitive and specific PCR-based assay to detect the Helicobacter pylon 16S rRNA gene present in formalin-fixed paraffin-embedded gastric biopsy specimens has been developed. A total of 95 patients with dyspepsia were evaluated for the presence of chronic active gastritis and an infection with H. pylori through the use of diagnostic assays based on biopsy specimens and serology. The "gold standard" for the presence of the bacteria was direct detection in histological sections of biopsy specimens by Giemsa stain. The results obtained with the PCR assay performed on the biopsy specimens (94% sensitivity and 100%6 specificity) were equivalent to the detection of H. pylori immunoglobulin G antibodies by the commercially available second-generation Cobas Core anti-H. pylori immunoglobulin G enzyme immunoassay (94% sensitivity and 98% specificity) for the diagnosis of H. pylori infection. Urease testing and bacterial culture of the biopsy specimens were inferior (88 and 70%o sensitivity and 96 and 98% specificity, respectively). A Western blot (immunoblot) analysis had slightly greater sensitivity (96%), although specificity was reduced to 93%. This research prototype PCR assay was shown to be highly reliable for the detection of infection with H. pylori and the presence of chronic active gastritis in the population studied.
gastritis in the population studied.
The bacterium Helicobacter pyloni is an etiologic agent for chronic active gastritis and plays a major role in effecting peptic ulcers (2, 9, 28) . Colonization of the human stomach and duodenum with this microorganism is widespread throughout the world, although the prevalence in different populations varies. Detection of H. pylori in an individual suffering from abdominal dyspepsia can affect the therapeutic course of treatment, since the presence of gastritis and a greater probability of an ulcer can thus be assumed. Thus, a decision to perform an endoscopy may be indicated, as would treatment with antibiotics. Eradication of H. pylon in patients with ulcers drastically reduces the chance of recurrence (13) .
There are several diagnostic assays for the detection of infection with H. pylon. Indirect assays that measure the presence of specific serum anti-H. pylon immunoglobulin G (IgG) and/or IgA using various antigen preparations purified to different degrees and serological techniques have been evaluated (8, 31) . There have been problems with serological cross-reactivity with some of the antigen preparations leading to a low level of specificity; however, a recent study utilizing several commercial kits has indicated acceptable performances dependent on the population studied (25) . Direct demonstration of an H. pylon infection in gastric biopsy specimens is possible through the use of culture, histologic examination of biopsy specimens using different stains, and assaying for urease activity. Recently, assays based on the use of the PCR to detect the presence of H. pylon DNA using several different gene targets have been described (3, 5, 12, 14, 16, 29, 30, 32, 34) .
These assays have been tested to date with only limited numbers of gastric biopsy specimens (3, 5, Results of culture and the urease assay. Biopsy specimens were subjected to a test for urease enzymatic activity (Campylobacter-like organism test), and two specimens were cultured for H. pylori. All patients with evidence of H. pylori infection by culture (n = 36) showed histologic evidence of H. pylori in the biopsy specimens, with one exception. Patient 95 had a positive culture result, although with only rare growth of bacteria, while all other analyses using the biopsy specimens or serum were negative for H. pylori infection. However, biopsy specimens from 15 patients shown to be infected with H. pylori did not produce positive cultures, resulting in a 70% sensitivity of the culture method (Table 1 ). The urease test results for the 95 biopsy specimens were positive for 46 samples, two of which (specimens 8 and 41) were from patients with no other indication of H. pyloni infection. The biopsy specimens from six patients (patients 22, 25, 32, 59, 80, and 86) with H. pyloni infections resulted in no detectable urease activity, and the biopsy specimens from five of these patients were also negative by culture.
DISCUSSION
The presence of H. pyloni bacteria in the upper gastrointestinal tract was directly associated with a histologic demonstration of chronic active gastritis and gastric ulcers in the patients enrolled in this study. The percentage of patients who harbored H. pyloni infections (53%) is consistent with the results of other studies of similar populations (8, 10, 15) . Importantly, the clinical presentation of the patients and endoscopy did not reveal which patients were infected. The presence of the bacteria and, indirectly, the chronic active gastritis were shown to be readily assessed in this study by several different assays with a high degree of accuracy. We found that a PCR assay that detects DNA encoding the H. pylori 16S rRNA gene in formalin-fixed paraffin-embedded biopsy specimens had a high degree of accuracy for demonstrating the presence of the bacteria and chronic active gastritis, as did the Cobas Core EIA performed with patients' sera. Conversely, the presence of normal gastric mucosa was consistent with an absence of bacteria. This is the first study both in which a PCR assay was evaluated for a large number of patients (95) and in which the results were compared with four other diagnostic parameters.
A diagnostic assay that does not require invasive procedures to procure specimens offers an advantage if it can be shown to be highly specific and sensitive for infection. In our study, the second-generation Cobas Core EIA proved to be robust and reproducible when performed multiple times by different laboratories, and the results obtained were highly predictive. This EIA has been shown to be highly specific and sensitive when applied to a similar European population (8, 18, 20 The other diagnostic assays used to detect the presence of H. pylori bacteria in biopsy specimens, the urease test and culture, did not perform as well. There was no discernible pattern as to when these assays failed; a lack of sensitivity when there were low numbers of organisms present was not the problem. In contrast to these findings, culture was found to be equivalent in sensitivity to PCR amplification of DNA from frozen biopsied tissue for the detection of H. pylori (30) . The poorer performance of culture and the urease test in our study may be due to specimen handling, since the organism is quite fastidious and sensitive to environmental conditions for sustained viability.
The 16S rRNA gene target for the PCR assay utilized in this study is similar to that described by Ho et (22, 23) . At this point, the additional genetic and/or environmental factors that lead to gastric cancer have not been identified; thus, screening of only limited populations would be warranted.
